Taxable
MBS Issuance in 3Q17 Was Up Solidly From Previous Period; ABS Production Weakened
$550.00
SEC Considering Moving Forward with Requiring Loan-Level Disclosures for More Types of ABS
$55.00
Strong Demand for Rated MBS Backed by Re-performing Loans; Chimera Issues First Deal and MetLife is Ready
$55.00